Skip to main content
. Author manuscript; available in PMC: 2016 Mar 30.
Published in final edited form as: Neurosci Lett. 2015 Feb 9;591:19–24. doi: 10.1016/j.neulet.2015.02.013

Table 1.

Clinicopathological data of study subjects.

Case # Pathological diagnosis Age (years) Gender Postmortem delay (h) Clinical diagnosis and complications CERAD neuritic plaque score Braak neurofibrillary tangle stage Analysis
1 Control 81 F 3.0 Myocardial infarction, congestive heart failure, renal failure A II qPCR
2 Control 78 M 2.7 Coronary artery disease, chronic, obstructive pulmonary disease, congestive heart failure, diabetes mellitus, hip bone fracture, cardiac pacemaker 0 II qPCR
3 Control 82 F 2.0 Lung cancer, myocardiac infarction A II qPCR
4 Control 73 F 1.5 Ovarian cancer 0 I qPCR
5 Control 85 F 2.5 Cardiac and respiratory failure, atrial fibrillation, cerebrovascular, accident (right hemiplegia) 0 III qPCR
6 Control 78 M 1.7 Lung cancer, heart failure 0 I qPCR, ISH
7 Control 85 M 3.2 Congestive heart failure 0 II qPCR, ISH
8 Control 88 F 3.0 Chronic renal failure 0 II qPCR
9 Control 86 M 2.5 Renal failure, attrial fabrillation, coronary artery disease, congestive heart failure 0 II ISH
10 AD 89 F 3.0 AD, osteoarthritis, anxiety, depression, aspiration pneumonia C V qPCR
11 AD 79 M 2.0 AD C V qPCR
12 AD 89 F 3.0 AD bronchopneumonia C V qPCR
13 AD 80 F 2.2 AD, parkinsonism C VI qPCR
14 AD 91 F 3.0 AD C V qPCR
15 AD 87 M 3.0 AD parkinsonism C V qPCR
16 AD 89 F 2.5 AD C VI qPCR
17 AD 61 F 2.5 AD, uterus cancer, bronchitis C VI ISH
18 AD 73 F 2.0 AD, atrial fibrillation, cerebrovascular accident C V ISH
19 AD 81 M 3.0 AD, cardiac and respiratory failure, C V ISH

AD: Alzheimer's disease, qPCR: quantitative polymerase chain reaction, ISH: in situ hybridization histochemistry.